TESARO (TSRO) Sets IPO Price Range at $12-$15/Share
Tweet Send to a Friend
TESARO, Inc. (Nasdaq: TSRO) filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The company will offer 6 million shares in the range of $12-$15 per share. TESARO plans to list on the Nasdaq Global Market under the ticker "TSRO."
The offering is being made through Citigroup, Morgan Stanley, Leerink Swann, BMO Capital Markets, and Baird.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The offering is being made through Citigroup, Morgan Stanley, Leerink Swann, BMO Capital Markets, and Baird.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- TESARO to Present at the Deutsche Bank 38th Annual 2013 Health Care Conference
- Evoke Pharma (EVOK) Files $24M IPO
- Ply Gem (PGEM) IPO Opens Higher
Create E-mail Alert Related Categories
IPOsRelated Entities
Citi, Morgan Stanley, Robert W Baird, BMO Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
